{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:58:48Z","timestamp":1760144328898,"version":"build-2065373602"},"reference-count":189,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.rmr.2022.08.009","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T05:03:37Z","timestamp":1663218217000},"page":"740-757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Marqueurs de s\u00e9v\u00e9rit\u00e9 et marqueurs pr\u00e9dictifs de r\u00e9ponse au traitement dans l\u2019asthme s\u00e9v\u00e8re"],"prefix":"10.1016","volume":"39","author":[{"given":"L.","family":"Ses\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mahay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Barnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Guibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Guilleminault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2022.08.009_bib0950","unstructured":"WHO. [Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/asthma."},{"key":"10.1016\/j.rmr.2022.08.009_bib0955","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1016\/j.rmr.2018.10.018","article-title":"Pr\u00e9valence et prise en charge de l\u2019asthme de l\u2019adulte en France en 2018: enqu\u00eate ASTHMAPOP","volume":"36","author":"Raherison-Semjen","year":"2019","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2022.08.009_bib0960","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib0965","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib0970","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2500\/aap.2015.36.3908","article-title":"Severe asthma: epidemiology, burden of illness, and heterogeneity","volume":"36","author":"Lang","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.rmr.2022.08.009_bib0975","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40413-017-0159-y","article-title":"Severe asthma and quality of life","volume":"10","author":"Hossny","year":"2017","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.rmr.2022.08.009_bib0980","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2018.10.002","article-title":"Clinical and economic burden of severe asthma: A French cohort study","volume":"144","author":"Nordon","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib0985","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1183\/09031936.03.00261903","article-title":"cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma","volume":"22","author":"The","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib0990","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1081-1206(10)61707-3","article-title":"Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma","volume":"92","author":"Dolan","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib0995","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jaip.2020.12.062","article-title":"Factors Associated with Frequent Exacerbations in the UK Severe Asthma Registry","volume":"9","author":"Yang","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2022.08.009_bib1000","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1005","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/all.13370","article-title":"Comorbid \u201ctreatable traits\u201d in difficult asthma: Current evidence and clinical evaluation","volume":"73","author":"Tay","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1010","doi-asserted-by":"crossref","first-page":"00069","DOI":"10.1183\/23120541.00069-2019","article-title":"FASE-CPHG study: a panoramic snapshot of difficult-to-treat, severe asthma in French nonacademic hospitals","volume":"5","author":"Portel","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmr.2022.08.009_bib1015","doi-asserted-by":"crossref","first-page":"465801","DOI":"10.1088\/0953-8984\/25\/46\/465801","article-title":"Low intensity conduction states in FeS2: implications for absorption, open-circuit voltage and surface recombination","volume":"25","author":"Lazic","year":"2013","journal-title":"J Phys Condens Matter"},{"key":"10.1016\/j.rmr.2022.08.009_bib1020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","volume":"178","author":"Haldar","year":"2008","journal-title":"Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1030","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/all.12136","article-title":"Three phenotypes of adult-onset asthma","volume":"68","author":"Amelink","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1035","doi-asserted-by":"crossref","first-page":"1702523","DOI":"10.1183\/13993003.02523-2017","article-title":"Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study","volume":"51","author":"Humbert","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cea.13373","article-title":"Asthma with multiple allergic comorbidities is associated with complete response to omalizumab","volume":"49","author":"Sese","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1045","doi-asserted-by":"crossref","first-page":"1800936","DOI":"10.1183\/13993003.00936-2018","article-title":"Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma","volume":"52","author":"Bleecker","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2213-2600(20)30414-8","article-title":"Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial","volume":"9","author":"Harrison","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1055","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1513\/AnnalsATS.201312-454OC","article-title":"Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma","volume":"11","author":"Ortega","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmr.2022.08.009_bib1060","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s40265-019-01221-x","article-title":"A Review in Moderate to Severe Asthma","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.rmr.2022.08.009_bib1065","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jaci.2006.01.033","article-title":"Severe asthma: an overview","volume":"117","author":"Moore","year":"2006","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.rmr.2022.08.009_bib1070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1183\/09031936.04.00077803","article-title":"Parameters associated with persistent airflow obstruction in chronic severe asthma","volume":"24","author":"Bumbacea","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1075","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1164\/ajrccm.158.6.9803014","article-title":"Sputum metalloproteinase-9\/tissue inhibitor of metalloproteinase-1\u00a0ratio correlates with airflow obstruction in asthma and chronic bronchitis","volume":"158","author":"Vignola","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1080","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1152\/japplphysiol.00329.2007","article-title":"Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation","volume":"104","author":"Sorkness","year":"2008","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1085","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1398-9995.2007.01383.x","article-title":"Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients","volume":"62","author":"Sullivan","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1090","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1378\/chest.07-0713","article-title":"Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study","volume":"132","author":"Lee","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.08.009_bib1095","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1164\/rccm.2108009","article-title":"Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1\/vital capacity ratio: a longitudinal population study from childhood to adulthood","volume":"165","author":"Rasmussen","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1183\/09031936.00080007","article-title":"Lung function decline in asthma","volume":"30","author":"Sears","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1105","unstructured":"[Internet] GMR. Global Initiative for Asthma - GINA. [cited 2022\u00a0Jan 21]. [Available from: https:\/\/ginasthma.org\/gina-reports\/."},{"key":"10.1016\/j.rmr.2022.08.009_bib1110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S2213-2600(19)30049-9","article-title":"Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study","volume":"7","author":"Postma","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1183\/09031936.00165106","article-title":"Severe exacerbations predict excess lung function decline in asthma","volume":"30","author":"Bai","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1120","doi-asserted-by":"crossref","first-page":"1701785","DOI":"10.1183\/13993003.01785-2017","article-title":"Predictors of accelerated decline in lung function in adult-onset asthma","volume":"51","author":"Coumou","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1183\/09031936.00135907","article-title":"Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma","volume":"32","author":"van Veen","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1130","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/thx.2010.156489","article-title":"Associations between fluctuations in lung function and asthma control in two populations with differing asthma severity","volume":"66","author":"Thamrin","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2022.08.009_bib1135","doi-asserted-by":"crossref","first-page":"106243","DOI":"10.1016\/j.rmed.2020.106243","article-title":"Prevalence and features of IOS-defined small airway disease across asthma severities","volume":"176","author":"Cottini","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1140","first-page":"382","article-title":"Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health\/National Heart","volume":"127","author":"Fitzpatrick","year":"2011","journal-title":"Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12931-020-01558-y","article-title":"Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER","volume":"21","author":"Singh","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.rmr.2022.08.009_bib1150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","article-title":"Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002\u00a0step 4\u00a0treatment): INNOVATE","volume":"60","author":"Humbert","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2022.08.009_bib1160","doi-asserted-by":"crossref","first-page":"00204","DOI":"10.1183\/23120541.00204-2019","article-title":"Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma","volume":"6","author":"Castro","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmr.2022.08.009_bib1165","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/all.13202","article-title":"Lung function parameters in omalizumab responder patients: An interesting tool?","volume":"72","author":"Paganin","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1170","doi-asserted-by":"crossref","first-page":"2001319","DOI":"10.1183\/13993003.01319-2020","article-title":"F ENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma","volume":"55","author":"Dinh-Xuan","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1175","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thoraxjnl-2018-211540","article-title":"Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis","volume":"73","author":"Petsky","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2022.08.009_bib1180","doi-asserted-by":"crossref","first-page":"1902150","DOI":"10.1183\/13993003.02150-2019","article-title":"Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1185","doi-asserted-by":"crossref","first-page":"1901633","DOI":"10.1183\/13993003.01633-2019","article-title":"Clinical utility of fractional exhaled nitric oxide in severe asthma management","volume":"55","author":"Menzies-Gow","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1190","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1164\/rccm.200905-0695OC","article-title":"Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma","volume":"181","author":"Dweik","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1195","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1200","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaip.2018.04.043","article-title":"Omalizumab effectiveness by biomarker status in patients with asthma: evidence from PROSPERO,. A prospective real-world study","volume":"7","author":"Casale","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2022.08.009_bib1205","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201903-0599LE","article-title":"Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide, and their combination in severe asthma: a post hoc analysis","volume":"200","author":"Shrimanker","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1210","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/cea.13378","article-title":"Severe asthma-A population study perspective","volume":"49","author":"Backman","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1215","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jaci.2016.06.059","article-title":"Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents","volume":"138","author":"Pongracic","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/JAA.S130459","article-title":"Sensitization to Aspergillus species is associated with frequent exacerbations in severe asthma","volume":"10","author":"Goh","year":"2017","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1225","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1398-9995.2009.02119.x","article-title":"Relationship between pretreatment specific IgE and the response to omalizumab therapy","volume":"64","author":"Wahn","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1230","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaip.2019.08.050","article-title":"Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma","volume":"8","author":"Corren","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2022.08.009_bib1235","doi-asserted-by":"crossref","first-page":"141","DOI":"10.18176\/jiaci.0035","article-title":"Component-based allergen-microarray: Der p 2\u00a0and Der f 2\u00a0dust mite sensitization is more common in patients with severe asthma","volume":"26","author":"Sylvestre","year":"2016","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1240","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000510118","article-title":"Mite molecular profile in the Th2-polarized moderate-to-severe persistent asthma endotype subjected to high allergen exposure","volume":"182","author":"Gonzalez-Perez","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1245","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaci.2020.02.031","article-title":"Connectivity patterns between multiple allergen specific IgE antibodies and their association with severe asthma","volume":"146","author":"Roberts","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1250","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.14-2457","article-title":"Biomarker profiles in asthma with high vs low airway reversibility and poor disease control","volume":"148","author":"Busse","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.08.009_bib1255","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s12325-019-01191-2","article-title":"Ability of serum IgE concentration to predict exacerbation risk and benralizumab efficacy for patients with severe eosinophilic asthma","volume":"37","author":"Jackson","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.rmr.2022.08.009_bib1260","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/cea.13613","article-title":"Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype","volume":"50","author":"Pelaia","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1265","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaip.2017.08.037","article-title":"Tiotropium respimat add-on is efficacious in symptomatic asthma, independent of T2\u00a0Phenotype","volume":"6","author":"Casale","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2022.08.009_bib1270","first-page":"66","article-title":"Correlation of eosinophil cationic protein with severity of asthma","volume":"16","author":"Badar","year":"2004","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"10.1016\/j.rmr.2022.08.009_bib1275","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.rmed.2006.08.012","article-title":"Eosinophil cationic protein: is it useful in asthma?. A systematic review","volume":"101","author":"Koh","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1280","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4168\/aair.2019.11.1.16","article-title":"Biomarkers for recurrent wheezing and asthma in preschool children","volume":"11","author":"Lee","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.rmr.2022.08.009_bib1285","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/all.13814","article-title":"An emerging biomarker for allergic diseases","volume":"74","author":"Izuhara","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1290","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clinbiochem.2016.10.002","article-title":"Multicenter evaluation of analytical characteristics of the Elecsys((R)) Periostin immunoassay","volume":"50","author":"Palme","year":"2017","journal-title":"Clin Biochem"},{"key":"10.1016\/j.rmr.2022.08.009_bib1295","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/all.15197","article-title":"Baseline type 2\u00a0biomarker levels and response to tezepelumab in severe asthma","volume":"77","author":"Corren","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1300","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/cyto.2002.1972","article-title":"Analysis of novel disease-related genes in bronchial asthma","volume":"19","author":"Yuyama","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.rmr.2022.08.009_bib1305","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.resinv.2020.02.003","article-title":"Role of serum periostin in the management of asthma and its comorbidities","volume":"58","author":"Matsumoto","year":"2020","journal-title":"Respir Investig"},{"key":"10.1016\/j.rmr.2022.08.009_bib1310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","article-title":"Composite type-2\u00a0biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial","volume":"9","author":"Heaney","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1315","article-title":"The pathological anatomy of bronchial asthma","author":"A.G.E.","year":"1908","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rmr.2022.08.009_bib1320","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00281-021-00849-w","article-title":"Lessons learned from targeting eosinophils in human disease","volume":"43","author":"Kuang","year":"2021","journal-title":"Semin Immunopathol"},{"issue":"2\u00a0Pt 1","key":"10.1016\/j.rmr.2022.08.009_bib1325","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/ajrccm.161.2.9903097","article-title":"Induced sputum cell counts in healthy adults","volume":"161","author":"Belda","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1330","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4103\/lungindia.lungindia_73_16","article-title":"Correlation of total serum immunoglobulin E level, sputum, and peripheral eosinophil count in assessing the clinical severity in bronchial asthma","volume":"34","author":"Kumar","year":"2017","journal-title":"Lung India"},{"key":"10.1016\/j.rmr.2022.08.009_bib1335","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/cea.13310","article-title":"Variability of blood eosinophils in patients in a clinic for severe asthma","volume":"49","author":"Rakowski","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1340","first-page":"1","article-title":"Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice","volume":"9","author":"Price","year":"2016","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1345","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1350","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmr.2022.08.009_bib1355","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1360","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(17)30344-2","article-title":"Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies","volume":"6","author":"FitzGerald","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1365","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1370","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3\u00a0trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2022.08.009_bib1375","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1380","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/all.13679","article-title":"CCR10(+) ILC2s with ILC1-like properties exhibit a protective function in severe allergic asthma","volume":"74","author":"Beuraud","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1385","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/cea.12741","article-title":"Elevated levels of circulating CD4(+) CRTh2(+) T cells characterize severe asthma","volume":"46","author":"Palikhe","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1390","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.rmr.2020.09.010","article-title":"Lung imaging in severe asthma","volume":"38","author":"Debray","year":"2021","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2022.08.009_bib1395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2016.11.009","article-title":"Using imaging as a biomarker for asthma","volume":"139","author":"Trivedi","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1400","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2016.19627","article-title":"Reevaluation of diagnosis in adults with physician-diagnosed asthma","volume":"317","author":"Aaron","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2022.08.009_bib1405","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40413-018-0207-2","article-title":"Confounders of severe asthma: diagnoses to consider when asthma symptoms persist despite optimal therapy","volume":"11","author":"Gherasim","year":"2018","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1410","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2049-6958-8-32","article-title":"Prevalence of tracheobronchomalacia and excessive dynamic airway collapse in bronchial asthma of different severity","volume":"8","author":"Dal Negro","year":"2013","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1415","doi-asserted-by":"crossref","first-page":"983","DOI":"10.21037\/atm-21-2243","article-title":"Retrospective comparison of high-resolution computed tomography of eosinophilic granulomatosis with polyangiitis with severe asthma","volume":"9","author":"Lin","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1420","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.rmed.2018.05.003","article-title":"Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis","volume":"139","author":"Nakamoto","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1425","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.4187\/respcare.02350","article-title":"Two cases of tracheal disease misdiagnosed as difficult-to-treat asthma","volume":"58","author":"Alici","year":"2013","journal-title":"Respir Care"},{"key":"10.1016\/j.rmr.2022.08.009_bib1430","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2214\/AJR.19.22628","article-title":"Diffuse idiopathic pulmonary neuroendocrine Cell hyperplasia: imaging and clinical features of a frequently delayed diagnosis","volume":"215","author":"Little","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1435","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2169\/internalmedicine.51.7621","article-title":"A patient with relapsing polychondritis who had been diagnosed as intractable bronchial asthma","volume":"51","author":"Sato","year":"2012","journal-title":"Internal medicine (Tokyo, Japan)"},{"key":"10.1016\/j.rmr.2022.08.009_bib1440","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1183\/09031936.00099812","article-title":"Hypereosinophilic obliterative bronchiolitis: a distinct unrecognised syndrome","volume":"41","author":"Cordier","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1445","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1378\/chest.09-0174","article-title":"Qualitative analysis of high-resolution CT scans in severe asthma","volume":"136","author":"Gupta","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.08.009_bib1450","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000064018","article-title":"High-resolution computed tomography findings are correlated with disease severity in asthma","volume":"69","author":"Harmanci","year":"2002","journal-title":"Respiration"},{"key":"10.1016\/j.rmr.2022.08.009_bib1455","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.acra.2018.09.023","article-title":"The association between bronchial wall CT attenuation and spirometry in patients with bronchial asthma","volume":"26","author":"Matsushita","year":"2019","journal-title":"Academic radiology"},{"key":"10.1016\/j.rmr.2022.08.009_bib1460","first-page":"186","article-title":"High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness","volume":"7","author":"Park","year":"1997","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1465","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/ajrccm\/146.4.1084","article-title":"Chest radiography and high resolution computed tomography of the lungs in asthma","volume":"146","author":"Paganin","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmr.2022.08.009_bib1470","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00330-012-2743-4","article-title":"Relationship between the airway wall area and asthma control score in moderate persistent asthma","volume":"23","author":"Brillet","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1475","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1378\/chest.07-2779","article-title":"Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology","volume":"134","author":"Aysola","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.08.009_bib1480","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/thx.2010.136374","article-title":"Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes","volume":"65","author":"Gupta","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2022.08.009_bib1485","doi-asserted-by":"crossref","first-page":"312","DOI":"10.18176\/jiaci.0265","article-title":"Severe asthma phenotypes classified by site of airway involvement and remodeling via chest CT scan","volume":"28","author":"Kim","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1490","doi-asserted-by":"crossref","first-page":"10187","DOI":"10.1038\/s41598-017-10504-w","article-title":"Relationship between fraction of exhaled nitric oxide and airway morphology assessed by three-dimensional CT analysis in asthma","volume":"7","author":"Nishimoto","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.rmr.2022.08.009_bib1495","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1109\/TMI.2014.2316115","article-title":"Volumetric quantification of airway wall in CT via collision-free active surface model: application to asthma assessment","volume":"33","author":"Fetita","year":"2014","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.rmr.2022.08.009_bib1500","doi-asserted-by":"crossref","first-page":"2100329","DOI":"10.1183\/13993003.00329-2021","article-title":"Evaluation of bronchial wall thickness in asthma using magnetic resonance imaging","volume":"59","author":"Benlala","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1505","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jaci.2020.02.029","article-title":"Ventilation defects on hyperpolarized helium-3\u00a0MRI in asthma are predictive of 2-year exacerbation frequency","volume":"146","author":"Mummy","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1510","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1515","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.anai.2014.06.004","article-title":"Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study","volume":"113","author":"Tajiri","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1520","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.chest.2020.04.056","article-title":"Effects of anti-T2\u00a0biologic treatment on lung ventilation evaluated by MRI in adults with prednisone-dependent asthma","volume":"158","author":"Svenningsen","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.08.009_bib1525","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/thoraxjnl-2019-213415","article-title":"Normalisation of MRI ventilation heterogeneity in severe asthma by dupilumab","volume":"74","author":"Svenningsen","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2022.08.009_bib1530","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiol.2462070712","article-title":"glossary of terms for thoracic imaging","volume":"246","author":"Hansell","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.rmr.2022.08.009_bib1535","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/02770903.2013.796973","article-title":"Allergic bronchopulmonary aspergillosis: a clinico-serological correlation with radiologic profile","volume":"50","author":"Kumar","year":"2013","journal-title":"J Asthma"},{"key":"10.1016\/j.rmr.2022.08.009_bib1540","doi-asserted-by":"crossref","first-page":"e23858","DOI":"10.1097\/MD.0000000000023858","article-title":"Clinical features of asthma with comorbid bronchiectasis: a systematic review and meta-analysis","volume":"100","author":"Zhang","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.rmr.2022.08.009_bib1545","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.anai.2018.02.016","article-title":"Bronchiectasis in severe asthma: clinical features and outcomes","volume":"120","author":"Coman","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1550","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02770903.2019.1579832","article-title":"Severe asthma and bronchiectasis","volume":"57","author":"Garc\u00eda-Clemente","year":"2020","journal-title":"J Asthma"},{"key":"10.1016\/j.rmr.2022.08.009_bib1555","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/crj.12653","article-title":"Investigation of bronchiectasis in severe uncontrolled asthma","volume":"12","author":"Dimakou","year":"2018","journal-title":"Clin Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1560","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jaip.2018.10.016","article-title":"The severe asthma network in Italy: findings and perspectives","volume":"7","author":"Heffler","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2022.08.009_bib1565","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s10875-016-0335-9","article-title":"Asthma and hypogammaglobulinemia: an asthma phenotype with low type 2\u00a0inflammation","volume":"36","author":"Dupin","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1570","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MCP.0000000000000542","article-title":"Bronchiectasis in severe asthma: a distinct phenotype?","volume":"25","author":"Perez-Miranda","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1575","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/JAA.S196200","article-title":"Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab","volume":"12","author":"Carpagnano","year":"2019","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1580","doi-asserted-by":"crossref","first-page":"106491","DOI":"10.1016\/j.rmed.2021.106491","article-title":"Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: a real-world retrospective pilot study","volume":"185","author":"Crimi","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1585","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/biomedicines9070772","article-title":"T2-High endotype and response to biological treatments in patients with bronchiectasis","volume":"9","author":"Oriano","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.rmr.2022.08.009_bib1590","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/cea.14026","article-title":"Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis","volume":"52","author":"Di Bona","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1595","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tips.2008.04.003","article-title":"Small airways: an important but neglected target in the treatment of obstructive airway diseases","volume":"29","author":"Sturton","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.rmr.2022.08.009_bib1600","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaci.2013.09.039","article-title":"Quantitative computed tomography-derived clusters: redefining airway remodeling in asthmatic patients","volume":"133","author":"Gupta","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1605","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S2213-2600(21)00536-1","article-title":"ATLANTIS studu group. The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study","volume":"10","author":"Kraft","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1610","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2021.01.029","article-title":"metrics are associated with longitudinal lung function decline and future asthma exacerbations: Results from SARP-3","volume":"148","author":"Krings","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1615","doi-asserted-by":"crossref","first-page":"e0168680","DOI":"10.1371\/journal.pone.0168680","article-title":"Altered Epithelial Gene Expression in Peripheral Airways of Severe Asthma","volume":"12","author":"Singhania","year":"2017","journal-title":"PloS one"},{"key":"10.1016\/j.rmr.2022.08.009_bib1620","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1365-2222.2012.03963.x","article-title":"Do small airway abnormalities characterize asthma phenotypes? In search of proof","volume":"42","author":"Contoli","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1625","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2500\/aap.2014.35.3741","article-title":"The effect of omalizumab on small airway inflammation as measured by exhaled nitric oxide in moderate-to-severe asthmatic patients","volume":"35","author":"Pasha","year":"2014","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.rmr.2022.08.009_bib1630","doi-asserted-by":"crossref","first-page":"101899","DOI":"10.1016\/j.pupt.2020.101899","article-title":"Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life","volume":"61","author":"Sposato","year":"2020","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.rmr.2022.08.009_bib1635","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1073\/pnas.87.5.1663","article-title":"Amplified RNA synthesized from limited quantities of heterogeneous cDNA","volume":"87","author":"Van Gelder","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rmr.2022.08.009_bib1640","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1073\/pnas.082089499","article-title":"Comprehensive human genome amplification using multiple displacement amplification","volume":"99","author":"Dean","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rmr.2022.08.009_bib1645","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0888-7543(92)90147-K","article-title":"Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer","volume":"13","author":"Telenius","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.rmr.2022.08.009_bib1650","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature09807","article-title":"Tumour evolution inferred by single-cell sequencing","volume":"472","author":"Navin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.rmr.2022.08.009_bib1655","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nmeth.1315","article-title":"mRNA-Seq whole-transcriptome analysis of a single cell","volume":"6","author":"Tang","year":"2009","journal-title":"Nat Methods"},{"key":"10.1016\/j.rmr.2022.08.009_bib1660","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1164\/rccm.201911-2199OC","article-title":"A single-cell atlas of the human healthy airways","volume":"202","author":"Deprez","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1665","doi-asserted-by":"crossref","first-page":"e27041","DOI":"10.7554\/eLife.27041","article-title":"The human cell atlas","volume":"6","author":"Regev","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.rmr.2022.08.009_bib1670","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41591-019-0468-5","article-title":"A cellular census of human lungs identifies novel cell states in health and in asthma","volume":"25","author":"Vieira Braga","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1675","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.201512-2452OC","article-title":"A Transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED","volume":"195","author":"Kuo","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1680","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.dld.2017.12.027","article-title":"Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: results from a web-based study","volume":"50","author":"Loubet","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.rmr.2022.08.009_bib1685","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa064707","article-title":"Asthma control during the year after bronchial thermoplasty","volume":"356","author":"Cox","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1690","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1164\/rccm.200704-571OC","article-title":"Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma","volume":"176","author":"Pavord","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1695","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-2600(20)30408-2","article-title":"Safety and effectiveness of bronchial thermoplasty after 10\u00a0years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials","volume":"9","author":"Chaudhuri","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1700","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1152\/japplphysiol.01282.2003","article-title":"Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs","volume":"97","author":"Danek","year":"2004","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.rmr.2022.08.009_bib1705","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaci.2016.08.009","article-title":"Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: Clinical and histopathologic correlations","volume":"139","author":"Pretolani","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1710","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/resp.13887","article-title":"Bronchial thermoplasty: redefining its role","volume":"25","author":"Langton","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.rmr.2022.08.009_bib1715","doi-asserted-by":"crossref","first-page":"2001616","DOI":"10.1183\/13993003.01616-2020","article-title":"Bronchial thermoplasty in patients with dynamic hyperinflation: results from the proof-of-concept HEAT trial","volume":"57","author":"Guibert","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1720","doi-asserted-by":"crossref","first-page":"1900300","DOI":"10.1183\/13993003.00300-2019","article-title":"Bronchial thermoplasty decreases airway remodelling by blocking epithelium-derived heat shock protein-60\u00a0secretion and protein arginine methyltransferase-1\u00a0in fibroblasts","volume":"54","author":"Sun","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1725","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jaci.2015.10.017","article-title":"Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways","volume":"137","author":"Denner","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1730","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaci.2015.11.044","article-title":"Reduction in peripheral blood eosinophil counts after bronchial thermoplasty","volume":"138","author":"Ryan","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1735","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jaip.2019.10.034","article-title":"Predicting the response to bronchial thermoplasty","volume":"8","author":"Langton","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2022.08.009_bib1740","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201911-2298OC","article-title":"Bronchial thermoplasty induced airway smooth muscle reduction and clinical response in severe asthma. The TASMA Randomized Trial","volume":"203","author":"Goorsenberg","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1745","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1164\/ajrccm.165.7.2103044","article-title":"The role of indoor allergen sensitization and exposure in causing morbidity in women with asthma","volume":"165","author":"Lewis","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1750","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1034\/j.1398-9995.2000.00293.x","article-title":"Sensitivity to fungal allergens is a risk factor for life-threatening asthma","volume":"55","author":"Black","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1755","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/bmj.325.7361.411","article-title":"Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey","volume":"325","author":"Zureik","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.rmr.2022.08.009_bib1760","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1183\/09031936.00073312","article-title":"Smoking and asthma: dangerous liaisons","volume":"41","author":"Polosa","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.08.009_bib1765","doi-asserted-by":"crossref","first-page":"00190","DOI":"10.1183\/23120541.00190-2021","article-title":"Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma","volume":"7","author":"Morobeid","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmr.2022.08.009_bib1770","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.jaip.2021.02.022","article-title":"Household cleaning and poor asthma control among elderly women","volume":"9","author":"Dumas","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2022.08.009_bib1775","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3390\/ijerph18031138","article-title":"The exposome approach to decipher the role of multiple environmental and lifestyle determinants in asthma","volume":"18","author":"Guillien","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.rmr.2022.08.009_bib1780","doi-asserted-by":"crossref","first-page":"110422","DOI":"10.1016\/j.envres.2020.110422","article-title":"Profile of exposures and lung function in adults with asthma: An exposome approach in the EGEA study","volume":"196","author":"Guillien","year":"2021","journal-title":"Environ Res"},{"key":"10.1016\/j.rmr.2022.08.009_bib1785","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrmicro.2017.14","article-title":"The microbiota of the respiratory tract: gatekeeper to respiratory health","volume":"15","author":"Man","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1790","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaci.2014.11.011","article-title":"The microbiome in asthma","volume":"135","author":"Huang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1795","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jaci.2019.06.025","article-title":"Associations between fungal and bacterial microbiota of airways and asthma endotypes","volume":"144","author":"Sharma","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1800","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaci.2016.08.055","article-title":"Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment","volume":"140","author":"Durack","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1805","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jaci.2018.04.013","article-title":"Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles","volume":"141","author":"Ghebre","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2022.08.009_bib1810","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2022.08.009_bib1815","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201809-1739OC","article-title":"Long-term azithromycin reduces haemophilus influenzae and increases antibiotic resistance in severe asthma","volume":"200","author":"Taylor","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.08.009_bib1820","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI124611","article-title":"Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases","volume":"129","author":"Agache","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmr.2022.08.009_bib1825","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1164\/ajrccm\/142.6_Pt_1.1351","article-title":"Genetics of asthma and hay fever in Australian twins","volume":"142","author":"Duffy","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmr.2022.08.009_bib1830","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41588-017-0014-7","article-title":"Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks","volume":"50","author":"Demenais","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.rmr.2022.08.009_bib1835","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/all.13499","article-title":"et al., 17q21\u00a0variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use","volume":"73","author":"Farzan","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1840","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1111\/all.13568","article-title":"Protective effects of breastfeeding on respiratory symptoms in infants with 17q21\u00a0asthma risk variants","volume":"73","author":"Gorlanova","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1845","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1111\/all.14243","article-title":"ORMDL3\u00a0but not neighboring 17q21\u00a0gene LRRC3C is expressed in human lungs and lung cells of asthmatics","volume":"75","author":"Hur","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1850","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/all.13745","article-title":"A strategy for high-dimensional multivariable analysis classifies childhood asthma phenotypes from genetic, immunological, and environmental factors","volume":"74","author":"Krautenbacher","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1855","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/all.14125","article-title":"IL1RL1\u00a0gene variations are associated with asthma exacerbations in children and adolescents using inhaled corticosteroids","volume":"75","author":"Dijk","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1860","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/all.13450","article-title":"Genetic predisposition to obesity is associated with asthma in US Hispanics\/Latinos: results from the Hispanic Community Health Study\/Study of Latinos","volume":"73","author":"Guo","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib1865","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41467-019-14144-8","article-title":"Eighty-eight variants highlight the role of T cell regulation and airway remodeling in asthma pathogenesis","volume":"11","author":"Olafsdottir","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.rmr.2022.08.009_bib1870","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.rmr.2022.08.009_bib1875","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0140-6736(13)61536-6","article-title":"Asthma","volume":"382","author":"Martinez","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2022.08.009_bib1880","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2217\/epi-2016-0162","article-title":"Epigenetics and allergy: from basic mechanisms to clinical applications","volume":"9","author":"Potaczek","year":"2017","journal-title":"Epigenomics"},{"key":"10.1016\/j.rmr.2022.08.009_bib1885","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/all.13746","article-title":"DNA methylation and allergic sensitizations: a genome-scale longitudinal study during adolescence","volume":"74","author":"Zhang","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2022.08.009_bib0945","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12890-020-01303-7","article-title":"Integrated genomics analysis highlights important SNPs and genes implicated in moderate-to-severe asthma based on GWAS and eQTL datasets","volume":"20","author":"Dong","year":"2020","journal-title":"BMC Pulm Med"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842522002856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842522002856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:23:42Z","timestamp":1760106222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842522002856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":189,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0761842522002856"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2022.08.009","relation":{},"ISSN":["0761-8425"],"issn-type":[{"type":"print","value":"0761-8425"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marqueurs de s\u00e9v\u00e9rit\u00e9 et marqueurs pr\u00e9dictifs de r\u00e9ponse au traitement dans l\u2019asthme s\u00e9v\u00e8re","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2022.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}